Contineum Therapeutics, Inc. ($CTNM)
Filing Information
| Accession Number | 0001628280-26-046653 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 1, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
30,000
Total Value
$170,805.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Class A Common Stock | โ | Jun 30, 2026 | Exercise/Conversion | 7,500 | $1.01 | $7,575.00 | 24,717 | Direct | โ | View Details | |
Director | Class A Common Stock | โ | Jun 30, 2026 | Exercise/Conversion | 2,500 | $1.26 | $3,150.00 | 27,217 | Direct | โ | View Details | |
Director | Class A Common Stock | โ | Jun 30, 2026 | Sale | 10,000 | $16.01 | $160,080.00 | 17,217 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jun 30, 2026 | Exercise/Conversion | 7,500 | $0.00 | $0.00 | 281,930 | Direct | โ | View Details | |
Director | Stock Option (right to buy) | Derivative | Jun 30, 2026 | Exercise/Conversion | 2,500 | $0.00 | $0.00 | 118,417 | Direct | โ | View Details |